{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:41:05Z","timestamp":1785552065067,"version":"3.56.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.vaccine.2008.02.044","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T04:41:00Z","timestamp":1206074460000},"page":"2211-2224","source":"Crossref","is-referenced-by-count":33,"title":["Despite Leishvaccine and Leishmune\u00ae trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis"],"prefix":"10.1016","volume":"26","author":[{"given":"M\u00e1rcio Sobreira Silva","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Aline de","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Rocha","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Mayrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Sathler-Avelar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maril\u00e9ia Chaves","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Norma","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.02.044_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.02.044_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1590\/S0074-02762005000800001","article-title":"Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review","volume":"100","author":"Lainson","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2008.02.044_bib3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniasis and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vetpar.2004.05.019","article-title":"Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission","volume":"122","author":"Moreira","year":"2004","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-4017(02)00351-5","article-title":"Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State","volume":"111","author":"Franca-Silva","year":"2003","journal-title":"Brazil Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2001.65.510","article-title":"Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil","volume":"65","author":"Palatnik-de-Sousa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.02.044_bib7","series-title":"Fourteenth Programme Report. UNDP\/World Bank\/Special Programme for Research and Training in Tropical Diseases (TDR). Tropical Disease Research Progress 1997\u20131998","article-title":"Leishmaniasis","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.vaccine.2008.02.044_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0035-9203(96)90293-X","article-title":"Visceral leishmaniasis in the hoary zorro Dusicyon vetulus: a case of mistaken identity","volume":"90","author":"Courtenay","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.02.044_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2006.05.001","article-title":"Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine","volume":"141","author":"Dantas-Torres","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.02.044_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0001-706X(93)90006-W","article-title":"Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose-mannose ligand (FML)","volume":"53","author":"Palatnik-de-Sousa","year":"1993","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2008.02.044_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A Phase III trial of efficacy of the FMLvaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.02.044_bib13","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2008.02.044_bib14","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.vaccine.2004.01.072","article-title":"Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins","volume":"23\/22","author":"Palatnik de Sousa","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.02.044_bib15","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.02.044_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/172.4.1055","article-title":"Identification of Leishmania chagasi antigens recognized by human lymphocytes","volume":"172","author":"Jeronimo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.02.044_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/1566524043360212","article-title":"Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis","volume":"4","author":"Ravindran","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2008.02.044_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"44","key":"10.1016\/j.vaccine.2008.02.044_bib19","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.044_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1090-0233(97)80006-8","article-title":"Studies of canine leucocyte antigens: a significant advance in canine immunology","volume":"153","author":"Williams","year":"1997","journal-title":"Vet J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.02.044_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-0039.1994.tb02315.x","article-title":"Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW)","volume":"43","author":"Cobbold","year":"1994","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.vaccine.2008.02.044_bib22","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1002\/j.1460-2075.1989.tb08540.x","article-title":"Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium","volume":"8","author":"Stuart","year":"1989","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.044_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.11606\/issn.2176-7262.v38i1p82-95","article-title":"Receptores para Imunoglobulina G (FcgR)","volume":"38","author":"Marzocchi-Machado","year":"2005","journal-title":"Medicina (Ribeir\u00e3o Preto)"},{"issue":"2\u20134","key":"10.1016\/j.vaccine.2008.02.044_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(97)00154-2","article-title":"Expression of adhesion and Fcgamma-receptors on canine blood eosinophils and neutrophils studied by anti-human monoclonal antibodies","volume":"61","author":"Lillieh\u00f6\u00f6k","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4269\/ajtmh.1990.42.118","article-title":"Canine visceral leishmaniasis in northeast Brazil: assessment of serodiagnostic methods","volume":"42","author":"Evans","year":"1990","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2307\/3283159","article-title":"Canine leishmaniasis: pathological and ecological factors influencing transmission of infection","volume":"77","author":"Abranches","year":"1991","journal-title":"J Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.044_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.02.044_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0738-081X(96)00041-7","article-title":"Leishmaniasis reservoirs and their significance in control","volume":"14","author":"Ashford","year":"1996","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniosis","volume":"2\u201310","author":"Baneth","year":"2002","journal-title":"Vet Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3164.2005.00460.x","article-title":"Treatment of canine Old World visceral leishmaniasis: a systematic review","volume":"16","author":"Noli","year":"2005","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib31","doi-asserted-by":"crossref","unstructured":"Giunchetti RC, Reis AB, da Silveira-Lemos D, Martins-Filho OA, Corr\u00eaa-Oliveira R, Bethony J, et al. Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis. Res Vet Sci; [Epub ahead of print], in press.","DOI":"10.1016\/j.rvsc.2007.09.008"},{"issue":"10","key":"10.1016\/j.vaccine.2008.02.044_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetimm.2004.08.023","article-title":"Expression and function of Toll-like receptor 2 in canine blood phagocytes","volume":"104","author":"Bazzocchi","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00160-9","article-title":"Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2","volume":"130","author":"Becker","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2005.11.005","article-title":"Triggering TLR signaling in vaccination","volume":"27","author":"van Duin","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/0008-5472.CAN-03-1518","article-title":"Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice","volume":"64","author":"Akazawa","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2008.02.044_bib37","first-page":"116","article-title":"Neutrophils as a source of immunoregulatory cytokines during microbial infection","volume":"6","author":"Denkers","year":"1998","journal-title":"Immunologist"},{"key":"10.1016\/j.vaccine.2008.02.044_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0952-7915(97)80156-2","article-title":"Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance","volume":"9","author":"Unanue","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-7915(97)80154-9","article-title":"Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-g)","volume":"9","author":"Trinchieri","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jcb.240530406","article-title":"Cytokine cross talk between phagocytic cells and lymphocytes: relevance for differentiation\/activation of phagocytic cells and regulation of adaptive immunity","volume":"53","author":"Trinchieri","year":"1993","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.vaccine.2008.02.044_bib41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4269\/ajtmh.1981.30.322","article-title":"Leishmanicidal mechanisms of human polymorphonuclear phagocytes","volume":"30","author":"Chang","year":"1981","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.02.044_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/00034983.1987.11812179","article-title":"Interaction of human eosinophils with Leishmania donovani","volume":"81","author":"Pearson","year":"1987","journal-title":"Ann Trop M\u00e9d Parasitol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2180-1-17","article-title":"In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection","volume":"1","author":"Rousseau","year":"2001","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib44","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.4049\/jimmunol.164.7.3681","article-title":"B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology","volume":"164","author":"Smelt","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.044_bib45","first-page":"115","article-title":"Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity","volume":"17","author":"Von Stebut","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.044_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2006.03206.x","article-title":"Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi","volume":"146","author":"Reis","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.044_bib47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1139\/o89-078","article-title":"The cell biology of T-dependent B cell activation","volume":"67","author":"Owens","year":"1989","journal-title":"Biochem Cell Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.02.044_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1471-4922(01)02086-4","article-title":"Fc receptors and immunity to parasites","volume":"17","author":"Pleass","year":"2001","journal-title":"Trends Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.02.044_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000076836","article-title":"Expression of functional activating and inhibitory Fcgamma receptors on human B cells","volume":"133","author":"Rabinovitch","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib50","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/eji.200636040","article-title":"Tolls for B cells","volume":"36","author":"Fillatreau","year":"2006","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-3083.2007.01909.x","article-title":"The cross-priming pathway: a portrait of an intricate immune system","volume":"65","author":"Basta","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib52","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"Eur J Immunol"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.02.044_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vetimm.2007.07.009","article-title":"Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis","volume":"15\u2013121","author":"Giunchetti","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib54","unstructured":"Pinelli E. Cytokines in canine visceral leishmaniasis. In: Schijns VECJ, Horzinek MC, editors. Cytokines in veterinary medicine (Cap. 14). 1997, p. 217\u201347."},{"key":"10.1016\/j.vaccine.2008.02.044_bib55","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib56","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20040172","article-title":"Low dose Leishmania major promotes a transient T helper cell type 2 response that is downregulated by interferon \u03b3-producing CD8+ T cells","volume":"199","author":"Uzonna","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.02.044_bib57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/intimm\/3.6.587","article-title":"Establishment of resistance to Leishmania major infection in susceptible BALB\/c mice requires parasite-specific CD8+ T cells","volume":"3","author":"M\u00fcller","year":"1991","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2008.02.044_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.0141-9838.2004.00668.x","article-title":"Cross-talk between CD8 and CD4 T cells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN-\u03b3 production by CD4+ T cells","volume":"25","author":"Herath","year":"2003","journal-title":"Parasite Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.02.044_bib59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2008.02.044_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0020-7519(03)00053-5","article-title":"Recent advances in veterinary vaccine adjuvants","volume":"33","author":"Singh","year":"2003","journal-title":"Int J Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/14760584.6.4.539","article-title":"Heterologous boost vaccines for bacillus Calmette-Gu\u00e9rin prime immunization against tuberculosis","volume":"6","author":"Xing","year":"2007","journal-title":"Expert Rev Vac"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.044_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0264-410X(91)90109-J","article-title":"Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors","volume":"9","author":"Takayama","year":"1991","journal-title":"Vaccine"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.02.044_bib63","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Kensil","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T09:02:45Z","timestamp":1588496565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":63,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0264410X08002351"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.02.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}